Arthur Pappas is the current director at OrphoMed. Prior to this, they were with CoLucid Pharmaceuticals, Inc. Pappas has also previously worked with AtheroGenics, Inc., Embrex, Inc., Pappas Capital, LLC, Quintiles Transnational, Inc., and Glaxo Holdings plc. Arthur Pappas began their career in 1971 with Merrell Dow Pharmaceuticals – The Dow Chemical Co. In 1987, they became vice president of international commercial operations at Abbott Laboratories International Ltd. Throughout their career, Pappas has held various management positions involving general management, marketing, and sales both domestically and internationally.
Arthur Pappas has a Bachelor of Science in Biology from Ohio State University and a Masters of Business Administration in Finance from Xavier University.
This person is not in the org chart